Rockwell Medical, Inc., together with its associated companies, operates as a biopharmaceutical firm specializing in treatments for chronic and end-stage kidney disease. ...
Rockwell Medical, Inc. is a fully-integrated biopharmaceutical company focused on treatments for chronic and end-stage kidney disease. Established in 1996 and headquartered in Wixom, Michigan, the company specializes in both innovative iron replacement therapies and essential hemodialysis products. Its key product line, Triferic (including Triferic Dialysate and Triferic AVNU), is an iron replacement therapy designed to maintain hemoglobin levels in dialysis patients without increasing iron stores. Beyond this, Rockwell Medical manufactures and distributes a comprehensive range of hemodialysis concentrates, including acid concentrates (CitraPure, Dri-Sate, RenalPure) and powder bicarbonate concentrates (RenalPure, SteriLyte), which are crucial for removing toxins and replacing essential nutrients in patients' blood. The company also supplies ancillary items such as blood tubing, fistula needles, dialyzers, dressings, and cleaning agents. Rockwell Medical primarily serves medium and small-sized dialysis chains and independent dialysis centers, aiming to become a leading global supplier of hemodialysis concentrates. The company is actively developing additional therapeutic candidates for acute heart failure and home infusion therapy. With a workforce of approximately 157 employees, Rockwell Medical has a strong focus on long-term growth and innovation, positioning itself as a key player in the dialysis market. Its operations span both domestic and international markets, supported by a dedicated team and a commitment to quality and life-sustaining solutions.
Church & Dwight Co., Inc.NYSE:CHDHawkins, Inc.NASDAQ:HWKNUnnamed Single-Use Bicarbonate Cartridge PartnerMultiple Unnamed US Chemical Raw Material SuppliersUnnamed Packaging Material SuppliersUnnamed Specialty Chemical Manufacturers
